Evidence map›Paper›PMID 34886043›Full record

ArticleInternational journal of environmental research and public health2021

Electrophoretic Determination of Trimethylamine (TMA) in Biological Samples as a Novel Potential Biomarker of Cardiovascular Diseases Methodological Approach.

Marek Konop, Mateusz Rybka, Emilia Waraksa, Anna K Laskowska, Artur Nowiński, Tomasz Grzywacz, Wojciech J Karwowski, Adrian Drapała, Ewa Maria Kłodzińska

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Marek KonopDepartment of Experimental Physiology and Pathophysiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, 02-106 Warsaw, Poland.ORCID 0000-0002-3914-6934
Mateusz RybkaDepartment of Experimental Physiology and Pathophysiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, 02-106 Warsaw, Poland.ORCID 0000-0003-0204-6101
Emilia WaraksaDepartment of Analytical Chemistry and Instrumental Analysis, Institute of Sport-National Research Institute, 01-879 Warsaw, Poland.
Anna K LaskowskaDepartment of Pharmaceutical Microbiology, Centre for Preclinical Research and Technology (CePT), Faculty of Pharmacy, Medical University of Warsaw, Banacha 1B, 02-097 Warsaw, Poland.
Artur NowińskiDepartment of Experimental Physiology and Pathophysiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, 02-106 Warsaw, Poland.
Tomasz GrzywaczDepartment of Sport, Institute of Physical Culture, Kazimierz Wielki University, 85-064 Bydgoszcz, Poland.ORCID 0000-0002-5398-6497
Wojciech J KarwowskiDepartment of Measurement and Electronics, Faculty of Electrical Engineering, Automatics, Computer Science and Biomedical Engineering, AGH University of Science and Technology, 02-106 Kraków, Poland.
Adrian DrapałaDepartment of Experimental Physiology and Pathophysiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, 02-106 Warsaw, Poland.
Ewa Maria KłodzińskaDepartment of Analytical Chemistry and Instrumental Analysis, Institute of Sport-National Research Institute, 01-879 Warsaw, Poland.ORCID 0000-0002-9931-5808
Medical University of Warsaw · PLInstytut Sportu · PLAGH University of Krakow · PLKazimierz Wielki University in Bydgoszcz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In competitive athletes, the differential diagnosis between nonpathological changes in cardiac morphology associated with training (commonly referred to as "athlete's heart") and certain cardiac diseases with the potential for sudden death is an important and not uncommon clinical problem. The use of noninvasive, fast, and cheap analytical techniques can help in making diagnostic differentiation and planning subsequent clinical strategies. Recent studies have demonstrated the role of gut microbiota and their metabolites in the onset and the development of cardiovascular diseases. Trimethylamine (TMA), a gut bacteria metabolite consisting of carnitine and choline, has recently emerged as a potentially toxic molecule to the circulatory system. The present work aims to develop a simple and cost-effective capillary electrophoresis-based method for the determination of TMA in biological samples. Analytical characteristics of the proposed method were evaluated through the study of its linearity (R

Indexed as

Cardiovascular DiseasesGastrointestinal MicrobiomeBiomarkersHumansMethylaminesBiomarkersMethylaminestrimethylaminebiomarkerscapillary electrophoresis (CE)cardiovascular diseases in athletesdetermination of trimethylamine (TMA)

Identifiers

PMID34886043
PMCPMC8656779
OpenAlexW3216728016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.